Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome
Annals of the Rheumatic Diseases · 2026-01 · 85 (1) · 212-215
DOI: 10.1016/j.ard.2025.09.012 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annals of the Rheumatic Diseases, 2026-01. Verfasst von Elpida Phithak und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: German Research Foundation, European Union's Research and Innovation, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany.
- German Rheumatism Research Centre (DRFZ) Berlin, a Leibnitz Institute, Berlin, Germany.
- Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Department of Rheumatology and Clinical Immunology, Immanuel Krankenhaus, Berlin, Germany.
- Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 13092 Berlin, Germany; German Cance…
Förderung
- German Research Foundation
- European Union's Research and Innovation
- Horizon 2020 Framework Programme
- European Commission
Zitieren
APA
Phithak, E., Albach, F. N., Minopoulou, I., Biesen, R., Kleyer, A., Wiebe, E., Siegert, E., Scholz, V., Rehm, M., Cheng, Q., Sattler, A., Bianco, S., Fleischmann, A., Hermann, K. G., Walter-Rittel, T., Wagner, M., Zernicke, J., Casteleyn, V., Nielsen, M., …, & Alexander, T. (2026). Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome. Annals of the Rheumatic Diseases, 85(1), 212-215. https://doi.org/10.1016/j.ard.2025.09.012
Vancouver
Phithak E, Albach FN, Minopoulou I, Biesen R, Kleyer A, Wiebe E, et al. Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome. Annals of the Rheumatic Diseases. 2026;85(1):212-215. doi:10.1016/j.ard.2025.09.012
BibTeX
@article{Phithak2026,
author = {Phithak, Elpida and Albach, Fredrik N and Minopoulou, Ioanna and Biesen, Robert and Kleyer, Arnd and Wiebe, Edgar and Siegert, Elise and Scholz, Veronika and Rehm, Marie and Cheng, Qingyu and Sattler, Arne and Bianco, Stefano and Fleischmann, Anja and Hermann, Kay-Geert and Walter-Rittel, Thula and Wagner, Moritz and Zernicke, Jan and Casteleyn, Vincent and Nielsen, Martin and Rose, Thomas and Busse, Antonia and Hütter-Krönke, Marie Luise and Keller, Ulrich and Schneider, Udo and Kawelke, Leona and Ruffer, Nikolas and Stenzel, Werner and Krönke, Gerhard and Simon, David and Alexander, Tobias},
title = {Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {1},
pages = {212--215},
doi = {10.1016/j.ard.2025.09.012}
}
EUVIMED